Home
VCYT
VCYT News

Latest Veracyte Inc. (VCYT) News on November 15, 2024

US Stocks Possibly Trading Below Fair Value Estimates In November 2024

Simply Wall St.

16 hours ago

US Stocks Possibly Trading Below Fair Value Estimates In November 2024

Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next

Simply Wall St.

6 days ago

Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next

Veracyte Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

7 days ago

Veracyte Third Quarter 2024 Earnings: Beats Expectations

MT Newswires

8 days ago

UBS Adjusts Price Target on Veracyte to $46 From $43, Maintains Buy Rating

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised

Zacks

8 days ago

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised

Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook

GuruFocus.com

8 days ago

Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook

Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates

Zacks

8 days ago

Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates

Associated Press Finance

8 days ago

Veracyte: Q3 Earnings Snapshot

Veracyte Announces Third Quarter 2024 Financial Results

Business Wire

8 days ago

Veracyte Announces Third Quarter 2024 Financial Results

What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings

GuruFocus.com

10 days ago

What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings

Veracyte to Participate in Upcoming Investor Conferences

Business Wire

15 days ago

Veracyte to Participate in Upcoming Investor Conferences

Paragon 28, Inc. (FNA) Stock Jumps 7.2%: Will It Continue to Soar?

Zacks

16 days ago

Paragon 28, Inc. (FNA) Stock Jumps 7.2%: Will It Continue to Soar?

Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024

Business Wire

a month ago

Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024

High Growth Tech Stocks To Watch In October 2024

Simply Wall St.

a month ago

High Growth Tech Stocks To Watch In October 2024

MT Newswires

a month ago

UBS Initiates Veracyte at Buy With $43 Price Target

Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 31% Discount?

Simply Wall St.

a month ago

Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 31% Discount?

How to Find Strong Buy Medical Stocks Using the Zacks Rank

Zacks

a month ago

How to Find Strong Buy Medical Stocks Using the Zacks Rank

MT Newswires

a month ago

Guggenheim Initiates Veracyte at Buy With $40 Price Target

Veracyte Inc (VCYT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance

GuruFocus.com

a month ago

Veracyte Inc (VCYT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance

Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today

Zacks

a month ago

Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today

Vanguard Group Inc's Strategic Acquisition of Veracyte Inc Shares

GuruFocus.com

a month ago

Vanguard Group Inc's Strategic Acquisition of Veracyte Inc Shares

New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men

Business Wire

a month ago

New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men

3 MedTech Stocks to Buy as Monetary Policy Eases

Zacks

2 months ago

3 MedTech Stocks to Buy as Monetary Policy Eases

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

2 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners

Zacks

2 months ago

Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners

Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago

Zacks

2 months ago

Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago

Zacks Industry Outlook Intuitive Surgical, Masimo and Veracyte

Zacks

2 months ago

Zacks Industry Outlook Intuitive Surgical, Masimo and Veracyte

New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

Business Wire

2 months ago

New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

3 Medical Instruments Industry Stocks to Buy on genAI and M&A Boost

Zacks

2 months ago

3 Medical Instruments Industry Stocks to Buy on genAI and M&A Boost

Exploring Three High Growth Tech Stocks in the United States

Simply Wall St.

2 months ago

Exploring Three High Growth Tech Stocks in the United States

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now

Zacks

2 months ago

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now

Insider Sale: Chief Commercial Officer-CLIA John Leite Sells Shares of Veracyte Inc (VCYT)

GuruFocus.com

2 months ago

Insider Sale: Chief Commercial Officer-CLIA John Leite Sells Shares of Veracyte Inc (VCYT)

Veracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue?

Zacks

2 months ago

Veracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue?

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks

Zacks

2 months ago

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks

Should You Continue to Retain ABT Stock in Your Portfolio Now?

Zacks

2 months ago

Should You Continue to Retain ABT Stock in Your Portfolio Now?

Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors

Business Wire

2 months ago

Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors

Here's Why Veracyte (VCYT) is a Strong Momentum Stock

Zacks

2 months ago

Here's Why Veracyte (VCYT) is a Strong Momentum Stock

5 Relative Price Strength Stocks That You Should Buy Now

Zacks

3 months ago

5 Relative Price Strength Stocks That You Should Buy Now

Is It Apt to Hold Globus Medical Stock in Your Portfolio Now?

Zacks

3 months ago

Is It Apt to Hold Globus Medical Stock in Your Portfolio Now?

MT Newswires

3 months ago

Needham Raises Price Target on Veracyte to $37 From $31, Maintains Buy Rating

Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Business Wire

3 months ago

Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle

Business Wire

3 months ago

Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle

Here’s Why Baron Discovery Fund Increased its Holdings in Veracyte (VCYT)

Insider Monkey

3 months ago

Here’s Why Baron Discovery Fund Increased its Holdings in Veracyte (VCYT)

Veracyte (VCYT) Just Flashed Golden Cross Signal: Do You Buy?

Zacks

3 months ago

Veracyte (VCYT) Just Flashed Golden Cross Signal: Do You Buy?

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?

Zacks

3 months ago

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

Zacks

3 months ago

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

Veracyte, Inc. (VCYT) Hit a 52 Week High, Can the Run Continue?

Zacks

3 months ago

Veracyte, Inc. (VCYT) Hit a 52 Week High, Can the Run Continue?

Veracyte, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.

3 months ago

Veracyte, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Insider Sale: Director Jens Holstein Sells 5,000 Shares of Veracyte Inc (VCYT)

GuruFocus.com

3 months ago

Insider Sale: Director Jens Holstein Sells 5,000 Shares of Veracyte Inc (VCYT)

Veracyte (VCYT) Q2 Earnings Beat Estimates, '24 Sales View Up

Zacks

3 months ago

Veracyte (VCYT) Q2 Earnings Beat Estimates, '24 Sales View Up

Veracyte Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

Veracyte Second Quarter 2024 Earnings: Beats Expectations

Diagnostic Tests Maker Veracyte's Q2 Is 'All-Around Very Good Quarter': Analysts Maintain Bullish View

Benzinga

3 months ago

Diagnostic Tests Maker Veracyte's Q2 Is 'All-Around Very Good Quarter': Analysts Maintain Bullish View

MT Newswires

3 months ago

Update: Veracyte Shares Surge After Q2 Beat, Higher Revenue Outlook

MT Newswires

3 months ago

Sector Update: Health Care Stocks Lean Higher Pre-Bell Wednesday

MT Newswires

3 months ago

Sector Update: Health Care

MT Newswires

3 months ago

Veracyte Q2 Non-GAAP Earnings, Revenue Increase; Raises Full-Year Sales Forecast Range

Veracyte (VCYT) Q2 Earnings and Revenues Beat Estimates

Zacks

3 months ago

Veracyte (VCYT) Q2 Earnings and Revenues Beat Estimates

Associated Press Finance

3 months ago

Veracyte: Q2 Earnings Snapshot

Veracyte Announces Second Quarter 2024 Financial Results

Business Wire

3 months ago

Veracyte Announces Second Quarter 2024 Financial Results

Insider Sale: Director Jens Holstein Sells 5,000 Shares of Veracyte Inc (VCYT)

GuruFocus.com

4 months ago

Insider Sale: Director Jens Holstein Sells 5,000 Shares of Veracyte Inc (VCYT)

Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024

Business Wire

4 months ago

Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024

Veracyte (VCYT) Stock Jumps 13.2%: Will It Continue to Soar?

Zacks

4 months ago

Veracyte (VCYT) Stock Jumps 13.2%: Will It Continue to Soar?

AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock?

Zacks

4 months ago

AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock?

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

Zacks

4 months ago

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

Market Sentiment Around Loss-Making Veracyte, Inc. (NASDAQ:VCYT)

Simply Wall St.

4 months ago

Market Sentiment Around Loss-Making Veracyte, Inc. (NASDAQ:VCYT)

3 Medical Instruments Picks to Navigate Industry Challenges

Zacks

5 months ago

3 Medical Instruments Picks to Navigate Industry Challenges

Zacks.com featured highlights Veracyte, Steelcase and Applied Industrial

Zacks

5 months ago

Zacks.com featured highlights Veracyte, Steelcase and Applied Industrial

Wall Street Analysts See a 37.09% Upside in Veracyte (VCYT): Can the Stock Really Move This High?

Zacks

5 months ago

Wall Street Analysts See a 37.09% Upside in Veracyte (VCYT): Can the Stock Really Move This High?

How to Find Strong Buy Medical Stocks Using the Zacks Rank

Zacks

5 months ago

How to Find Strong Buy Medical Stocks Using the Zacks Rank

Veracyte (VCYT) Up 8.4% Since Last Earnings Report: Can It Continue?

Zacks

5 months ago

Veracyte (VCYT) Up 8.4% Since Last Earnings Report: Can It Continue?

It's Unlikely That The CEO Of Veracyte, Inc. (NASDAQ:VCYT) Will See A Huge Pay Rise This Year

Simply Wall St.

5 months ago

It's Unlikely That The CEO Of Veracyte, Inc. (NASDAQ:VCYT) Will See A Huge Pay Rise This Year

Veracyte (NASDAQ:VCYT) investors are sitting on a loss of 40% if they invested three years ago

Simply Wall St.

5 months ago

Veracyte (NASDAQ:VCYT) investors are sitting on a loss of 40% if they invested three years ago

Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors

Business Wire

5 months ago

Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors

Wall Street Analysts Think Veracyte (VCYT) Could Surge 39.07%: Read This Before Placing a Bet

Zacks

6 months ago

Wall Street Analysts Think Veracyte (VCYT) Could Surge 39.07%: Read This Before Placing a Bet

Veracyte (VCYT) Crossed Above the 50-Day Moving Average: What That Means for Investors

Zacks

6 months ago

Veracyte (VCYT) Crossed Above the 50-Day Moving Average: What That Means for Investors

Veracyte (VCYT) Fell Due to a Lack of Rising Profitability

Insider Monkey

6 months ago

Veracyte (VCYT) Fell Due to a Lack of Rising Profitability

Zacks.com featured highlights include Veracyte, Signet Jewelers, UMB Financial and NVIDIA

Zacks

6 months ago

Zacks.com featured highlights include Veracyte, Signet Jewelers, UMB Financial and NVIDIA

Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners

Zacks

6 months ago

Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners

Veracyte's (VCYT) New Findings to Advance Thyroid Cancer Care

Zacks

6 months ago

Veracyte's (VCYT) New Findings to Advance Thyroid Cancer Care

Buy 5 Medical Instruments Stocks to Enhance Your Portfolio

Zacks

6 months ago

Buy 5 Medical Instruments Stocks to Enhance Your Portfolio

Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer

Business Wire

6 months ago

Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer

Veracyte (VCYT) Up 6% Since Last Earnings: Will it Continue?

Zacks

6 months ago

Veracyte (VCYT) Up 6% Since Last Earnings: Will it Continue?

Veracyte to Participate in Upcoming Investor Conferences

Business Wire

6 months ago

Veracyte to Participate in Upcoming Investor Conferences

Wall Street Analysts Believe Veracyte (VCYT) Could Rally 39.59%: Here's is How to Trade

Zacks

6 months ago

Wall Street Analysts Believe Veracyte (VCYT) Could Rally 39.59%: Here's is How to Trade

Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount?

Simply Wall St.

6 months ago

Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount?

Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript

Insider Monkey

6 months ago

Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript

Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View

Zacks

6 months ago

Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View

Thomson Reuters StreetEvents

6 months ago

Q1 2024 Veracyte Inc Earnings Call

GuruFocus.com

6 months ago

Veracyte Inc (VCYT) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with Revenue ...

Associated Press Finance

6 months ago

Veracyte: Q1 Earnings Snapshot

GuruFocus.com

6 months ago

Veracyte Inc (VCYT) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strong Test Performance

Veracyte Announces First Quarter 2024 Financial Results

Business Wire

6 months ago

Veracyte Announces First Quarter 2024 Financial Results

14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding

Business Wire

6 months ago

14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding

Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024

Business Wire

7 months ago

Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024

New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance

Business Wire

7 months ago

New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance

Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024

Business Wire

7 months ago

Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024

What Makes Veracyte (VCYT) a Lucrative Investment?

Insider Monkey

7 months ago

What Makes Veracyte (VCYT) a Lucrative Investment?

Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines

Business Wire

9 months ago

Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff

InvestorPlace

9 months ago

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff

Veracyte Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

9 months ago

Veracyte Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Share on Social Networks: